Development · 7 Sep 2026
2 publishers have reported this development. Each act of reporting is below, cited.
Molbio Diagnostics posted a profit of Rs 52.74 crore in the June quarter.
Molbio Diagnostics reported a consolidated net profit of Rs 58.75 crore in the quarter ended June 2026.
Molbio Diagnostics reported a consolidated net profit of Rs 58.75 crore in the quarter ended June 2026, with sales rising 309.57% to Rs 408.38 crore.
This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.
New here? The reader's guide explains every page, plate by plate.
fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.